Skip to main content

Discussion on LYNPARZA

When

03/31/21    
6:00 pm - 7:00 pm
Download ICS Google Calendar iCalendar Office 365 Outlook Live

Virtual Expert Discussion on LYNPARZA® (olaparib) 

Treatment of mCRPC with LYNPARZA:
An oral therapy for patients with HRR gene mutations following progression on enzalutamide or abiraterone

 

Presented by:

Kevin Lagman, MBA, MSN, APRN, FNP-C
Advanced Practice Provider, Department of Genitourinary
Medical Oncology
University of Texas MD Anderson Cancer Center
Houston, TX

 

To register or for more information, contact
Lynn Harris at 626-622-2658 or lynn.harris@astrazeneca.com